Lavaca Capital LLC
Source: SEC Form 13F · as of Mar 2026Lavaca Capital LLC holds 22 biotech & pharma companies tracked by BioSniper, totaling $4.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$4.9M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 14,014 | $1.7M |
| ABBVAbbVie Inc. | 2,169 | $472K |
| JNJJOHNSON & JOHNSON | 1,490 | $364K |
| LLYELI LILLY & Co | 386 | $355K |
| ABTABBOTT LABORATORIES | 3,373 | $346K |
| PMPhilip Morris International Inc | 2,023 | $334K |
| PFEPFIZER INC | 11,267 | $316K |
| IDXXIDEXX LABORATORIES INC /DE | 540 | $303K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 837 | $226K |
| GILDGILEAD SCIENCES, INC. | 1,489 | $208K |
| BIIBBIOGEN INC. | 447 | $82K |
| NVONovo Nordisk A/S | 840 | $31K |
| ELVElevance Health Inc. | 100 | $29K |
| ZTSZoetis Inc. | 197 | $23K |
| AZNASTRAZENECA PLC | 100 | $20K |
| BMYBRISTOL MYERS SQUIBB CO | 308 | $19K |
| NVSNovartis AG | 119 | $18K |
| BAXBaxter International Inc. | 1,000 | $17K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 154 | $8K |
| VTRSViatris Inc | 243 | $3K |
| OGNOrganon & Co. | 152 | $910 |
| GEHCGE HealthCare Technologies Inc. | 2 | $142 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.